Monopar Therapeutics Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ACRV
Acrivon Therapeutics, Inc. Common Stock |
$6.79 | $223.86 M | -2.51 | 58 | $0 |
![]() ACXP
Acurx Pharmaceuticals, Inc. |
$1.09 | $38.02 M | -2.03 | 4 | $0 |
![]() ADAG
Adagene Inc. |
$1.98 | $131.46 M | -6.77 | 174 | $18.11 M |
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
![]() ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
![]() AVTE
Aerovate Therapeutics, Inc. |
$2.70 | $597.48 M | -6.84 | 30 | $0 |
![]() CADL
Candel Therapeutics, Inc. |
$8.70 | $212.76 M | -5.54 | 42 | $0 |
![]() DMAC
DiaMedica Therapeutics Inc. |
$5.43 | $97.19 M | -4.74 | 18 | $0 |
![]() ENOB
Enochian Biosciences, Inc. |
$0.71 | $45.38 M | -0.34 | 22 | $0 |
![]() KTTA
Pasithea Therapeutics Corp. |
$3.09 | $5.84 M | -0.41 | 8 | $0 |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
![]() MOLN
Molecular Partners AG |
$5.06 | $135.05 M | -2.03 | 158 | $4.97 M |
![]() PEPG
PepGen Inc. |
$3.68 | $537.15 M | -5.11 | 81 | $0 |
![]() PHVS
Pharvaris N.V. |
$18.06 | $843.31 M | -5.8 | 92 | $0 |
![]() PMVP
PMV Pharmaceuticals, Inc. |
$1.57 | $85.40 M | -1.26 | 47 | $0 |
![]() RZLT
Rezolute, Inc. |
$5.21 | $229.57 M | -5.02 | 64 | $0 |
![]() SCPH
scPharmaceuticals Inc. |
$3.62 | $135.20 M | -2.53 | 135 | $13.59 M |
![]() SCPS
Scopus BioPharma Inc. |
$0.00 | $4,208 | 0 | 13 | $0 |